Alicia Aliena-Valero

6PUBLICATIONS
29CO-AUTHORS
Central nervous systemAutoimmunityCellular nervous systemNeurology and neuromuscular diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 28, 2026
The Senolytic Drug Navitoclax Protects the Brain After Experimental Ischemic Stroke.

Dianoush Falahatgaroshibi, Júlia Baixauli-Martín, María C Burguete

|May 02, 2025
Protective Effects of Interleukin-1 Inhibition With Anakinra in Mouse Models of Ischemic Stroke With and Without Reperfusion.

Nerea Chaparro-Cabanillas, Alicia Aliena-Valero, Jordi Pedragosa

|Mar 13, 2025
Spatio-Temporal Characterization of Cellular Senescence Hallmarks in Experimental Ischemic Stroke.

Júlia Baixauli-Martín, Maria Consuelo Burguete, Mikahela A López-Morales

|Jun 28, 2022
Brain Cell Senescence: A New Therapeutic Target for the Acute Treatment of Ischemic Stroke.

Júlia Baixauli-Martín, Alicia Aliena-Valero, María Castelló-Ruiz

|Jun 24, 2022
Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke.

Emma Martínez-Alonso, Alejandro Escobar-Peso, Alicia Aliena-Valero

|Aug 05, 2020
Endothelin-1-Mediated Drug Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma.

Inés Pulido, Stephen Ollosi, Salvador Aparisi

Pageof 1